欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
DK/H/3096/003
药品名称
Cresnisol
活性成分
Alanine 16.0 g/l
Arginine 10.9 g/l
Aspartic acid 3.2 g/l
Glutamic acid 5.53 g/l
Glycine 7.68 g/l
Histidine 6.6 g/l
Isoleucine 5.53 g/l
Leucine 7.68 g/l
Lysine 8.64 g/l
Methionine 5.53 g/l
Phenylalanine 7.68 g/l
Proline 6.6 g/l
Serine 4.38 g/l
Threonine 5.53 g/l
Tryptophan 1.85 g/l
Tyrosine 0.28 g/l
Valine 7.08 g/l
剂型
Solution for infusion
上市许可持有人
Baxter A/S Tobaksvejen 2 A 2860 Søborg Denmark
参考成员国 - 产品名称
Denmark (DK)
Cresnisol
互认成员国 - 产品名称
United Kingdom (Northern Ireland) (XI)
Ireland (IE)
France (FR)
Germany (DE)
Flosol 11,1 % Infusionslösung
许可日期
2021/01/13
最近更新日期
2024/12/12
药物ATC编码
B05BA01 amino acids
申请类型
TypeLevel1：
Known Active Substance
TypeLevel2：
Additional Strength/Form
TypeLevel3：
Bibliographic Art 10 a Dir 2001/83/EC
TypeLevel4：
Chemical Substance
TypeLevel5：
Prescription Only
附件文件下载
Final Labelling
|
common_interpack_cresnisol_n10_20210112
Date of last change:2024/09/06
Final Labelling
|
common_interpack_cresnisol_n18_20210112
Date of last change:2024/09/06
Final Labelling
|
common_interpack_cresnisol_n24_20210112
Date of last change:2024/09/06
Final PL
|
common_pl_cresnisol_wolytes_20210112
Date of last change:2024/09/06
Final SPC
|
common_spc_cresnisol_wolytes_20210112
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase